Intravenous Busulfan: In the Conditioning Treatment of Pediatric Patients Prior to Hematopoietic Stem Cell Transplantation

By Hoy Sheridan M.   Lyseng-Williamson Katherine A.  

Pediatric Drugs, Vol. 9, Iss. 4, 2007-01 ,pp. : 271-278

Adis International

Access to resources Recommend Favorite

Safety of conditioning agents for allogeneic haematopoietic transplantation

By Bacher Ulrike   Klyuchnikov Evgeny   Wiedemann Bettina   Kroeger Nicolaus   Zander Axel Rolf  

Expert Opinion on Drug Safety, Vol. 8, Iss. 3, 2009-05 ,pp. : 305-315

Informa Healthcare

Access to resources Recommend Favorite

Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma

By Martino Massimo   Olivieri Attilio   Offidani Massimo   Vigna Ernesto   Moscato Tiziana   Fedele Roberta   Montanari Mauro   Console Giuseppe   Gentile Massimo   Messina Giuseppe   Irrera Giuseppe   Morabito Fortunato  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 5, 2013-05 ,pp. : 619-634

Informa Healthcare

Access to resources Recommend Favorite

Reduced-toxicity conditioning with fludarabine, once-daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial

By Mohty Mohamad   Malard Florent   Blaise Didier   Milpied Noel   Furst Sabine   Tabrizi Resa   Guillaume Thierry   Vigouroux Stéphane   El-Cheikh Jean   Delaunay Jacques   Le Gouill Steven   Moreau Philippe   Labopin Myriam   Chevallier Patrice  

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 562-569

Blackwell Publishing

Access to resources Recommend Favorite

Intravenous vernakalant: a guide to its use in recent-onset atrial fibrillation

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 8, 2011-08 ,pp. : 6-10

Adis International

Access to resources Recommend Favorite